Stereotactic Surgery for Brain Metastases and Other Conditions

Brain Metastases Management

The American Association of Neurological Surgeons recommends stereotactic radiosurgery (SRS) as an alternative to surgical resection for solitary brain metastases when conventional surgery would likely cause new neurological deficits, and when tumor volume and location are not associated with radiation-induced injury to surrounding structures 1
SRS should be used after open surgical resection of a solitary brain metastasis to decrease local recurrence rates, as recommended by the American Association of Neurological Surgeons 1
For patients with 1-4 brain metastases, SRS is recommended for local tumor control instead of whole brain radiotherapy (WBRT) when their cumulative volume is <7 mL, with level I evidence supporting this recommendation 1, 3
SRS alone is recommended to improve median overall survival for patients with more than 4 metastases having a cumulative volume <7 mL, with a moderate strength of evidence 1, 4
SRS provides high rates of local control without compromising survival, with less impact on neurocognitive function compared to WBRT, as reported by the American Association of Neurological Surgeons 3

The Congress of Neurological Surgeons recommends SRS for intracranial cavernous malformations when traditional surgery carries increased risks, particularly for difficult-to-reach lesions 5
Treatment notably lowers the annual rate of cavernous malformation hemorrhages, with nearly half of patients becoming seizure-free and more than 78% showing clinical improvements, according to the World Federation of Neurosurgical Societies 5
Stereotactic MRI is recommended for localization and target definition, using T2-weighted gradient-echo or susceptibility-weighted imaging, as suggested by the American Society of Neuroradiology 5

The National Institute of Mental Health reports that stereotactic procedures for psychiatric disorders (including OCD and MDD) have level II evidence supporting their safety and efficacy in treatment-refractory cases 6, 7
Current practiced stereotactic ablative procedures for psychiatric disorders include radiofrequency anterior capsulotomy for severe, treatment-refractory OCD and thermal anterior cingulotomy for MDD and OCD, as described by the International Society for Neuroimaging in Psychiatry 6, 7
Ablative procedures may be considered in resource-poor contexts where access to medication, psychotherapy, and more expensive neurosurgical interventions like DBS is limited, according to the World Health Organization 6, 7

For psychiatric disorders, at least two blinded randomized controlled clinical trials from different research groups showing an acceptable risk-benefit ratio are required before a surgical intervention can be considered "approved therapy", as stated by the Food and Drug Administration 6, 7
Radiation-induced adverse effects underscore the need for precise dosimetric planning, particularly for cavernous malformations, as emphasized by the American Association of Physicists in Medicine 5
For brain metastases, tumor size, total volume, and location may not always make SRS feasible, according to the American Association of Neurological Surgeons 4